Advertisement

GI & Endoscopy

Array BioPharma and Merck formed a clinical trial collaboration agreement to investigate the safety and efficacy of Array's binimetinib, a MEK inhibitor, with Merck's Keytruda, an anti-PD-1 therapy, in metastatic colorectal cancer patients with microsatellite stable tumors.

Advertisement
Advertisement